SpecGx to Offer Covered Entities Refunds for a Record 30-Plus Years of 340B Overcharges
SpecGx, a generic subsidiary of Mallinckrodt Pharmaceuticals, will refund 340B covered entities that purchased addiction treatment medication Methadose for above [...]